These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 5511783
1. Occurrence of an abnormal lipoprotein in patients with liver disease. Ross A, Murphy GM, Wilkinson PA, Mills GL, Sherlock S. Gut; 1970 Dec; 11(12):1035-7. PubMed ID: 5511783 [Abstract] [Full Text] [Related]
2. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease. Ritland S. Scand J Gastroenterol; 1975 Dec; 10(1):5-15. PubMed ID: 164686 [Abstract] [Full Text] [Related]
3. [The significance of lipoprotein X in the diagnosis of obstructive jaundice: comparison with other biochemical tests (author's transl)]. Mayr K. Dtsch Med Wochenschr; 1975 Oct 24; 100(43):2193-7. PubMed ID: 240665 [Abstract] [Full Text] [Related]
5. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)]. Lachmann D. Wien Klin Wochenschr Suppl; 1977 Oct 24; 69():3-28. PubMed ID: 266315 [Abstract] [Full Text] [Related]
6. On the occurrence of lipoprotein-x in non-hemolytic jaundice. Samsioe G, Lundborg H, Ivarsson S, Gustafson A. Acta Chir Scand; 1976 Oct 24; 142(3):187-90. PubMed ID: 180734 [Abstract] [Full Text] [Related]
9. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases. Magnani HN, Alaupovic P. Gastroenterology; 1976 Jul 24; 71(1):87-93. PubMed ID: 179911 [Abstract] [Full Text] [Related]
10. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia. Sörös P, Böttcher J, Maschek H, Selberg O, Müller MJ. Hepatology; 1998 Nov 24; 28(5):1199-205. PubMed ID: 9794902 [Abstract] [Full Text] [Related]
11. The incidence and likely origins of serum particulate alkaline phosphatase and lipoprotein-X in liver disease. Brocklehurst D, Wilde CE, Doar JW. Clin Chim Acta; 1978 Sep 15; 88(3):509-15. PubMed ID: 699340 [Abstract] [Full Text] [Related]
12. Studies in cholestasis of pregnancy. Johnson P, Samsioe G, Gustafson A. Acta Obstet Gynecol Scand; 1975 Sep 15; 54(2):105-11. PubMed ID: 166548 [Abstract] [Full Text] [Related]
17. Hepatic secretion enzymes and electrophoretic lipoprotein fractions in liver disease. Tăpălagă D, Opincaru A, Cucuianu M. Acta Hepatogastroenterol (Stuttg); 1979 Feb 15; 26(1):9-16. PubMed ID: 34311 [No Abstract] [Full Text] [Related]
18. Changes in plasma lipids and abnormal lipoproteins in a patient with drug-induced cholestatic hepatitis. Miyahara K, Kasahara N, Kondo Y, Imai Y, Matuzaki F. Jpn J Med; 1991 Feb 15; 30(4):354-9. PubMed ID: 1942649 [Abstract] [Full Text] [Related]
19. Serum lipoprotein patterns in liver and heart disease. Papadopoulos NM, Bedynek JL. Ann Clin Lab Sci (1971); 1972 Feb 15; 2(5):343-7. PubMed ID: 4343278 [No Abstract] [Full Text] [Related]
20. LP-X in cholestasis. Tanno H, Fay O, Palazzi J, Pedrana R, Yäger E, Roncoroni M. Acta Hepatogastroenterol (Stuttg); 1975 Oct 15; 22(5):289-91. PubMed ID: 173123 [Abstract] [Full Text] [Related] Page: [Next] [New Search]